medigraphic.com
ISSN 1561-3070 (Electronic)

2020, Number 3

<< Back Next >>

Rev Cub Oftal 2020; 33 (3)

Risk factors associated to retinal vein occlusion

Chiang RC, Zhang H, Lapido PSI, Toledo GY, Chirino CAÁ

Language: Spanish
References: 25
Page: 1-16
PDF size: 426.73 Kb.


ABSTRACT

Objectives: Identify the epidemiological, systemic and ocular factors associated to retinal vein occlusion.
Methods: A descriptive cross-sectional observational prospective study was conducted of the new cases of retinal vein occlusion presenting at the Emergency Service of Ramón Pando Ferrer Cuban Institute of Ophthalmology from March 2017 to March 2018. Analysis was performed of epidemiological variables and systemic and ocular pathological antecedents. Results were expressed as absolute and relative frequencies (qualitative variables), whereas quantitative variables underwent mean and standard deviation estimation.
Results: Fifty eyes of 50 patients diagnosed with retinal vein occlusion were studied in the period. Mean age was 66 years (9.5 standard deviation). White skin color prevailed (44%) with no sex predominance. The most common disorders were central vein retinal occlusion (60%) and non-ischemic forms of vascular damage (78%), as well as arterial hypertension (78%), obesity (36%) and diabetes mellitus (34%) as associated systemic risk factors, and chronic glaucoma (24%) as an ocular factor.
Conclusions: Retinal vein occlusion presents at advanced ages and is associated to systemic and ocular risk factors.


REFERENCES

  1. Azhan A, Mutasim H, Abdul-Hadi R, Khairul-Anwar I, Zunaina E. Macular branch retinal vein occlusion: a revisit and case report. J Biomed Clin Sci. 2018;3(2):18-21.

  2. Gómez- Ulla F, Abraldes MJ, Basauri E, Fernández M, García-Layana E, Manzanaro PG, et al. Manejo de las oclusiones venosas de la retina. Guías de Práctica Clínica. 2015;5:1-49.

  3. Roger S, Mepid RL, Tien W, et al. The prevalence of retinal vein occlusion: Pooled data from population studies from de United States, Europe, Asia and Australia. Ophthalmology. 2010;117(2):313-9.

  4. Ho M, David TL, Lam DS, Jonas JB. Retinal vein occlusions, from basics to the latest treatment. Retina. 2016;36(3):432-48.

  5. Citirik M, Haznedaroglu IC. Clinical risk factors underlying the occurrence of retinal vein occlusion. Int J Ophthal Res.2016;2(1):91-5.

  6. Stem MS, Talwar N, Comer GM, Stein JD. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology. 2013;120(2):362-70.

  7. Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol; 2014:724780.

  8. Pascual CI, Hernández MP, Dolz MR, Gallego PR. Oclusión venosa retiniana en pacientes jóvenes y estudio sistémico. Caso clínico y revisión de la literatura. Arch Soc Esp Oftalmol. 2016;91(3):130-3.

  9. Abbdeiaziz M, Rostamizadeh M, Ahmad B. Branch retinal vein occlusion. American Academy of Ophthalmology; 2019 [acceso: 03/07/2020]. Disponible en: https://eyewiki.org/Branch_retinal_vein_occlusion

  10. The Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol. 1986;104(1):34-41.

  11. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115(4):486-91.

  12. Chiang Rodríguez C, Velázquez Villares Y, Santana Alas E. Obstrucción de la vena central de la retina. Oftalmología. Diagnóstico y tratamiento. La Habana: Editorial Ciencias Médicas; 2018. p. 331-4.

  13. Díaz GC, Moya MD, Murillo SM, Cabrera F, Burgos R, Rodrigo PM. Guías de tratamiento básico de las oclusiones venosas. Retina. 2019;9:111-20.

  14. Zhou JQ, Xu L, Wang S. The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. Ophthalmology. 2013;120(4):803-8.

  15. Sivaprasad S, Amoaku WM, Hykin P, et al. The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary. Eye. 2015;29:1633-8.

  16. Bessette A, Kaiser KP. Branch retinal vein occlusion. Ryan. 2018;2(56):3499-535.

  17. Oellers P, Hahn P, Fekrat S. Central retina vein occlusion. Ryan. 2018;2(57):3536-79.

  18. Lim LL, Cheung N, Wang JJ, Islam FM, Mitchell P, Saw SM, et al. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol. 2008;92(10):1316-9.

  19. Koh V, Cheung CY, Li X, Tian D, Wang JJ, Mitchell P, et al. Retinal vein occlusion in a multi-ethnic asian population: the Singapore epidemiology of eye disease study. Ophth Epidemiol. 2016;23(1):6-13.

  20. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133-43.

  21. Kumar SV. Clinical study of branch retinal vein occlusion. Int J Clin Trials. 2017;4(4):191-5.

  22. Ponto KA, Elbaz H, Peto T, Laubert-Reh D, Binder H, Wild PS, Lackner K, Pfeiffer N, Mirshahi A. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study. J Thromb Haemost. 2015;13(7):1254-63.

  23. Sánchez JG, Ocampo HH, Rodríguez FJ, Grisales MA, Caballero CA, Ruiz ÁJ. Terapias anti-VEGF en el tratamiento de enfermedades de la retina: Recomendaciones para la práctica en Colombia. Rev Soc Colomb Oftalmol. 2018;51(1):46-62.

  24. Pulido SJ, Flaxel JC, Adelman AR, Hyman L, Folk CJ, Olsen WT. The Eye Association. American Academy of Ophthalmology; 2016:182-208.

  25. Scruggs BA, Quist TS, Kravchuk O, Sohn EH. Branch retinal vein occlusion. Ophthalmol Vis Scien. 2018 [acceso: 03/07/2020]. Disponible en: https://webeye.ophth.uiowa.edu/eyeforum/cases/274-branch-retinal-vein-occlusion.htm




2020     |     www.medigraphic.com